DLK2
Protein delta homolog 2
Also known as: DLK2_HUMAN, EGFL9, MGC2487
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UY11
- Gene
- DLK2
- Ensembl
- ENSG00000171462
- Chromosome
- 6
- Canonical length
- 383 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Vesicles
OverviewNCBI Gene
Predicted to enable Notch binding activity. Involved in negative regulation of Notch signaling pathway. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
383 residues, UniProt reviewed canonical sequence.
>Q6UY11|DLK2
1 MPSGCRCLHL VCLLCILGAP GQPVRADDCS SHCDLAHGCC APDGSCRCDP GWEGLHCERC
61 VRMPGCQHGT CHQPWQCICH SGWAGKFCDK DEHICTTQSP CQNGGQCMYD GGGEYHCVCL
121 PGFHGRDCER KAGPCEQAGS PCRNGGQCQD DQGFALNFTC RCLVGFVGAR CEVNVDDCLM
181 RPCANGATCL DGINRFSCLC PEGFAGRFCT INLDDCASRP CQRGARCRDR VHDFDCLCPS
241 GYGGKTCELV LPVPDPPTTV DTPLGPTSAV VVPATGPAPH SAGAGLLRIS VKEVVRRQEA
301 GLGEPSLVAL VVFGALTAAL VLATVLLTLR AWRRGVCPPG PCCYPAPHYA PACQDQECQV
361 SMLPAGLPLP RDLPPEPGKT TALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DLK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- prostate: 12 nTPM
- skin: 12 nTPM
- esophagus: 12 nTPM
- cerebellum: 10 nTPM
- basal ganglia: 8.4 nTPM
- salivary gland: 7.6 nTPM
Single-cell type
- breast myoepithelial cells: 80 nCPM
- epididymal basal cells: 70 nCPM
- basal prostatic cells: 51 nCPM
- respiratory basal cells: 42 nCPM
- esophageal basal cells: 35 nCPM
- salivary basal cells: 34 nCPM
Immune cell
- MAIT T-cell: 0.8 nTPM
- NK-cell: 0.7 nTPM
- memory CD4 T-cell: 0.5 nTPM
- memory CD8 T-cell: 0.5 nTPM
- plasmacytoid DC: 0.5 nTPM
- basophil: 0.3 nTPM
Brain region
- cerebellum: 14 nTPM
- cerebral cortex: 9.8 nTPM
- basal ganglia: 8.7 nTPM
- hypothalamus: 8.1 nTPM
- hippocampal formation: 7.2 nTPM
- amygdala: 6.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.78
- gnomAD missense Z
- 1.93
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DLK2 as an antibody target. Whether an autoantibody or antibody against DLK2 could matter depends on whether native DLK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DLK2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DLK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...